CG
RGNX icon

Carmignac Gestion’s Regenxbio RGNX Stock Holding History

Carmignac Gestion’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46,369
Closed -$1.52M – 125
2021
Q4 		$1.52M Sell
46,369
-127,471
-73% -$4.34M 0.02% 107
2021
Q3 		$7.29M Sell
173,840
-12,699
-7% -$457K 0.09% 79
2021
Q2 		$7.25M Sell
186,539
-66,463
-26% -$2.38M 0.08% 80
2021
Q1 		$8.63M Buy
253,002
+166,600
+193% +$7.11M 0.1% 75
2020
Q4 		$3.92M Sell
86,402
-59,626
-41% -$2.08M 0.04% 90
2020
Q3 		$4.02M Sell
146,028
-27,164
-16% -$886K 0.05% 74
2020
Q2 		$6.38M Buy
173,192
+4,287
+3% +$160K 0.09% 68
2020
Q1 		$5.47M Sell
168,905
-120,376
-42% -$5.02M 0.09% 61
2019
Q4 		$11.9M Sell
289,281
-954,440
-77% -$37.7M 0.16% 50
2019
Q3 		$44.3M Sell
1,243,721
-138,541
-10% -$5.61M 0.56% 44
2019
Q2 		$71M Buy
1,382,262
+743,067
+116% +$37.1M 0.88% 39
2019
Q1 		$36.6M Buy
639,195
+467,869
+273% +$23.2M 0.43% 43
2018
Q4 		$7.19M Buy
171,326
+60,020
+54% +$3.52M 0.11% 66
2018
Q3 		$8.4M Buy
111,306
+33,305
+43% +$2.4M 0.07% 78
2018
Q2 		$5.6M Buy
+78,001
New +$3.72M 0.04% 85

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Carmignac Gestion's RGNX Position: Q1 2022 in Review

Carmignac Gestion sold out of Regenxbio (RGNX) in Q1 2022, closing a stake of 46,369 shares — an estimated $1.52M sold.

Carmignac Gestion first reported a position in RGNX in Q2 2018 and held it in 15 quarters. The position peaked at $71M in Q2 2019. 188 funds tracked by Wall St. Rank hold RGNX as of Q1 2022.

  • Carmignac Gestion reported no remaining Regenxbio position as of Q1 2022 after selling out during the quarter.
  • Carmignac Gestion sold 46,369 Regenxbio shares in Q1 2022, an estimated $1.52M.
  • Carmignac Gestion first reported a position in Regenxbio in Q2 2018 and held it in 15 quarters.
  • Carmignac Gestion's Regenxbio position peaked at $71M in Q2 2019.
  • 188 funds tracked by Wall St. Rank held Regenxbio as of Q1 2022.

Based on Carmignac Gestion's 13F filing for Q1 2022, filed 13 May 2022.